Receivable, after allowance for credit loss, current
Breakdown
Segments
Oncology, Neurology, and Immunology ProductView metric
Software contributionView metric
| Segment | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|
| Oncology, Neurology, and Immunology Product | $0 | $0 | $0 | $0 | $0 | $0 |
| Software contribution | $150M | $0 | $0 | $0 | $0 | $0 |
| Total | $235.69M | $20.35M | $10.07M | $29.38M | $83.04M | $27.25M |